Performance of prostate cancer antigen 3 (PCA3) and prostate-specific antigen in prescreened men: Reproducibility and detection characteristics for prostate cancer patients with high PCA3 scores (≥100)

European Urology

Volumn 58, Issue 6, 2010, Pages 893-899

  Roobol, Monique J ^a   Schröder, Fritz H ^a   Van Leenders, Geert L J H ^a   Hessels, Daphne ^a   Van Den Bergh, Roderick C N ^a   Wolters, Tineke ^a   Van Leeuwen, Pim J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Diagnosis; PCA3; Performance characteristics; Prostate cancer; PSA

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER SCREENING; CLINICAL EVALUATION; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; PERFORMANCE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; REPRODUCIBILITY; URINALYSIS;

AGED; ANTIGENS, NEOPLASM; BIOPSY; FREEZING; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NETHERLANDS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING;

EID: 78049478702     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2010.09.030     Document Type: Article

References (19)

1. M.J. Bussemakers, A. van Bokhoven, and G.W. Verhaegh DD3: a new prostate-specific gene, highly overexpressed in prostate cancer Cancer Res 59 1999 5975 5979
2. D. Hessels, J.M. Klein Gunnewiek, and I. van Oort DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer Eur Urol 44 2003 8 15
3. Y. Fradet, F. Saad, and A. Aprikian uPM3, a new molecular urine test for the detection of prostate cancer Urology 64 2004 311 315
4. J. Groskopf, S.M. Aubin, and I.L. Deras APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer Clin Chem 52 2006 1089 1095
5. I.L. Deras, S.M. Aubin, and A. Blase PCA3: a molecular urine assay for predicting prostate biopsy outcome J Urol 179 2008 1587 1592
6. M.J. Roobol, F.H. Schröder, and P. van Leeuwen Performance of the prostate cancer antigen 3 (PCA3) gene and prostate-specific antigen in prescreened men: exploring the value of PCA3 for a first-line diagnostic test Eur Urol 58 2010 475 481
7. E.W. Steyerberg, M.J. Roobol, M.W. Kattan, T.H. van der Kwast, H.J. de Koning, and F.H. Schröder Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram J Urol 177 2007 107 112
8. L.J. Sokoll, W. Ellis, and P. Lange A multicenter evaluation of the PCA3 molecular urine test: pre-analytical effects, analytical performance and diagnostic accuracy Clin Chim Acta 389 2008 1 6
9. S.B. Shappell, J. Fulmer, D. Arguello, B.S. Wright, J.R. Oppenheimer, and M.J. Putzi PCA3 urine mRNA testing for prostate carcinoma: patterns of use by community urologists and assay performance in a reference laboratory setting Urology 72 2009 363 368
10. M.P. van Gils, D. Hessels, and O. van Hooij The time-resolved fluorescene-based PCA3 test on urinary sediments after digital rectal examination; a Dutch multicenter validation of the diagnostic performance Clin Cancer Res 13 2007 939 943
11. L.S. Marks, Y. Fradet, and I.L. Deras PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy Urology 69 2007 532 535
12. A. Haese, A. de la Taille, and H. van Poppel Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy Eur Urol 54 2008 1081 1088
13. R. Wang, A.M. Chinnaiyan, R.L. Dunn, K.J. Wojno, and J.T. Wei Rational approach to implementation of prostate cancer antigen 3 into clinical care Cancer 115 2009 3879 3886
14. I. Popa, Y. Fradet, G. Beaudry, H. Hovington, and B. Tetu Identification of PCA3 (DD3) in prostatic carcinoma by in situ hybridization Mod Pathol 20 2007 1121 1127
15. Morote J, Rigau M, Garcia M, et al. Behavior of the PCA3 gene in the urine of men with high grade prostatic intraepithelial neoplasia. World J Urol. In press. DOI: 10.1007/s00345-010-0580-0.
16. M.P. van Gils, D. Hessels, W.P. Peelen, H. Vergunst, P.F. Mulders, and J.A. Schalken Preliminary evaluation of the effect of dutasteride on PCA3 in post-DRE urine sediments: a randomized, open-label, parallel-group pilot study Prostate 69 2009 1624 1634
17. F.K. Chun, A. de la Taille, and H. van Poppel Prostate cancer gene 3 (PCA3): development and internal validation of a novel biopsy nomogram Eur Urol 56 2009 659 668
18. C. Stephan, H. Rittenhouse, and H. Cammann New markers and multivariate models for prostate cancer detection Anticancer Res 29 2009 2589 2600
19. Roobol MJ, Hessels D, Vickers A, et al. Predicting prostate biopsy outcome in a screening setting. PSA, PCA3, a kallikrein panel, the risk calculator or a combination? ERSPC Rotterdam. Poster 974 presented at: European Association of Urology Annual Congress; April 16-20, 2010; Barcelona, Spain.